Showing results (631-640 of 815) with videos related to

Sort By:
Pageof 82
FEBS Letters|November 28, 1983
Ricin B chain converts a non-cytotoxic antibody-ricin A chain conjugate into a potent and specific cytotoxic agentD P McIntosh, D C Edwards, A J Cumber, et al.
Journal of Pediatric Intensive Care|June 23, 2015
Biomarkers and genetics of brain injury risk in diabetic ketoacidosis: A pilot studySholeen T Nett, Janelle A Noble, Daniel L Levin, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1989
The disposition of SK&F L-94901, a selective thyromimetic in rat, dog and cynomolgus monkeyM A Pue, J A Ransley, D J Writer, et al.
Vaccine|May 2, 2022
TAK - 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic miceKanami Tamura, Mai Kohnoe, Ayako Takashino, et al.
Biochemical and Biophysical Research Communications|November 20, 2002
A rat monoclonal antibody that catalyses the hydrolysis of a nitrophenyl-beta-lactamElizabeth L Ostler, Christopher J Dean, Nicola Barber, et al.
Schizophrenia Research|December 5, 2016
Beat gestures and postural control in youth at ultrahigh risk for psychosisK Juston Osborne, Jessica A Bernard, Tina Gupta, et al.
Vaccine|January 26, 2022
Characterization of the cell-mediated immune response to Takeda's live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic settingVianney Tricou, Raphael Gottardo, Michael A Egan, et al.
Journal of Intellectual Disability Research : JIDR|July 11, 2012
General practitioners' views on perceived and actual gains, benefits and barriers associated with the implementation of an Australian health assessment for people with intellectual disabilityN G Lennox, C E Brolan, J Dean, et al.
American Journal of Surgery|January 1, 1986
Cholestatic jaundice after hepatic transplantation. A nonimmunologically mediated eventJ W Williams, S Vera, T G Peters, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 25, 2010
Preclinical absorption, distribution, metabolism, excretion, and pharmacokinetic-pharmacodynamic modelling of N-(4-(3-((3S,4R)-1-ethyl-3-fluoropiperidine-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)-3-fluorophenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide, a novel MET kinase inhibitorBianca M Liederer, Leonid M Berezhkovskiy, Brian J Dean, et al.
Pageof 82